BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16256415)

  • 21. The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia.
    Romero IL; Barros Jde N; Martins MC; Ballalai PL
    Cornea; 2013 Jan; 32(1):36-9. PubMed ID: 22525782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of toluidine blue in the diagnosis of neoplastic lesions of the oral cavity].
    Barrellier P; Babin E; Louis MY; Meunier-Guttin A
    Rev Stomatol Chir Maxillofac; 1993; 94(1):51-4. PubMed ID: 8456246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV.
    Mashberg A
    JAMA; 1981 Jun; 245(23):2408-10. PubMed ID: 6164804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroral staining method with toluidine blue as an aid in the diagnosis of malignant gastric lesions.
    Giler S; Kadish U; Urca I
    Am J Gastroenterol; 1976 Jan; 65(1):37-40. PubMed ID: 1274928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
    Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB
    J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Toluidine blue (tolonium chloride) in the early diagnosis of dysplasias and carcinomas of the oral mucosa].
    Vercellino V; Gandolfo S; Camoletto D; Griffa B; Mori C
    Minerva Stomatol; 1985; 34(2):257-61. PubMed ID: 3889574
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis of oral squamous cell carcinoma and its precursor lesions.
    Driemel O; Kunkel M; Hullmann M; von Eggeling F; Müller-Richter U; Kosmehl H; Reichert TE
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1095-100. PubMed ID: 18042091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vital staining of squamous cell carcinoma of the conjunctiva using toluidine blue.
    Kaji Y; Hiraoka T; Oshika T
    Acta Ophthalmol Scand; 2006 Dec; 84(6):825-6. PubMed ID: 17083548
    [No Abstract]   [Full Text] [Related]  

  • 29. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.
    Upadhyay J; Rao NN; Upadhyay RB; Agarwal P
    Asian Pac J Cancer Prev; 2011; 12(7):1757-60. PubMed ID: 22126560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [White lesions of the oral mucosa. Auxiliary diagnostic methods].
    Amorin C; Caffarena MP
    An Fac Odontol; 1990 Dec; (26):21-6. PubMed ID: 2134728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostacyclin (PGI2) biosynthesis in oral squamous epithelium carcinoma and mouth mucosa in relation to clinical and histological findings].
    Schulz S; Mentz P; Timmel H; Giessler C
    Zahn Mund Kieferheilkd Zentralbl; 1986; 74(1):37-42. PubMed ID: 2938366
    [No Abstract]   [Full Text] [Related]  

  • 32. Methylene Blue as a Diagnostic Aid in the Early Detection of Potentially Malignant and Malignant Lesions of Oral Mucosa.
    Lejoy A; Arpita R; Krishna B; Venkatesh N
    Ethiop J Health Sci; 2016 May; 26(3):201-8. PubMed ID: 27358540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toluidine blue rinse: potential for benign lesions in early detection of oral neoplasms.
    Moyer GN; Taybos GM; Pelleu GB
    J Oral Med; 1986; 41(2):111-3. PubMed ID: 3459822
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toluidine blue staining in laryngeal diseases (author's transl)].
    Thomsen KA; Thomsen J
    Laryngol Rhinol Otol (Stuttg); 1975 Feb; 54(2):114-9. PubMed ID: 123616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of histochemical staining techniques for detecting mast cells in oral lesions.
    Mutsaddi S; Kotrashetti VS; Nayak RS; Pattanshetty SM
    Biotech Histochem; 2019 Aug; 94(6):459-468. PubMed ID: 30983422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toluidin blue in gastrointestinal endoscopy].
    Retter J; Collet PH; Böcker U; Singer MV; Kähler G
    Z Gastroenterol; 2010 Sep; 48(9):1117-9. PubMed ID: 20839160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions.
    Epstein JB; Güneri P
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):79-87. PubMed ID: 19374030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Toluidine blue solution as a diagnostic aid in oropharyngeal cancer].
    Gómez Serrano MT; Toranzo Fernández JM; Martínez Bravo J
    Rev ADM; 1989; 46(1):29-35. PubMed ID: 2634420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.